Classifications

• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
  • A61F13/00—Bandages or dressings; Absorbent pads
  • A61F13/02—Adhesive bandages or dressings
  • A61F13/0203—Adhesive bandages or dressings with fluid retention members
  • A61F13/0206—Adhesive bandages or dressings with fluid retention members with absorbent fibrous layers, e.g. woven or non-woven absorbent pads or island dressings
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
  • A61F13/00—Bandages or dressings; Absorbent pads
  • A61F13/02—Adhesive bandages or dressings
  • A61F13/0203—Adhesive bandages or dressings with fluid retention members
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
  • A61F13/00—Bandages or dressings; Absorbent pads
  • A61F13/02—Adhesive bandages or dressings
  • A61F13/0203—Adhesive bandages or dressings with fluid retention members
  • A61F13/0213—Adhesive bandages or dressings with fluid retention members the fluid retention member being a layer of hydrocolloid, gel forming material
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
  • A61F13/00—Bandages or dressings; Absorbent pads
  • A61F13/02—Adhesive bandages or dressings
  • A61F13/0203—Adhesive bandages or dressings with fluid retention members
  • A61F13/0223—Adhesive bandages or dressings with fluid retention members characterized by parametric properties of the fluid retention layer, e.g. absorbency, wicking capacity, liquid distribution
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
  • A61F13/00—Bandages or dressings; Absorbent pads
  • A61F13/02—Adhesive bandages or dressings
  • A61F13/0246—Adhesive bandages or dressings characterised by the skin-adhering layer
  • A61F13/0253—Adhesive bandages or dressings characterised by the skin-adhering layer characterized by the adhesive material
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
  • A61F13/00—Bandages or dressings; Absorbent pads
  • A61F13/05—Bandages or dressings; Absorbent pads specially adapted for use with sub-pressure or over-pressure therapy, wound drainage or wound irrigation, e.g. for use with negative-pressure wound therapy [NPWT]
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
  • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
  • A61M1/90—Negative pressure wound therapy devices, i.e. devices for applying suction to a wound to promote healing, e.g. including a vacuum dressing
  • A61M1/91—Suction aspects of the dressing
  • A61M1/912—Connectors between dressing and drainage tube
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
  • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
  • A61M1/90—Negative pressure wound therapy devices, i.e. devices for applying suction to a wound to promote healing, e.g. including a vacuum dressing
  • A61M1/91—Suction aspects of the dressing
  • A61M1/915—Constructional details of the pressure distribution manifold
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
  • A61F13/00—Bandages or dressings; Absorbent pads
  • A61F2013/00089—Wound bandages
  • A61F2013/0017—Wound bandages possibility of applying fluid
  • A61F2013/00174—Wound bandages possibility of applying fluid possibility of applying pressure

Definitions

• the subject matter disclosed herein relates generally to negative pressure dressings and to negative pressure tissue treatment devices having negative pressure dressings and, more particularly, to dressings that can be used with a source of negative pressure to deliver negative pressure therapy.
• Such dressings are suitable for the treatment of a variety of wounds including chronic and acute types, including infected wounds, venous ulcers, diabetic ulcers, burns, surgical wounds and the like.
• negative pressure is applied by a reduced pressure source to tissue through a porous pad or other manifold device that is sealed to a patient’s skin around the periphery of a wound or other tissue for which such treatment is prescribed.
• the porous pad includes cells or pores that are capable of distributing reduced pressure to the tissue and channeling fluids that are drawn from the tissue.
• the porous pad often is incorporated into a dressing having other components that facilitate treatment.
• the negative pressure may be applied continuously or intermittently, depending on the type of wound or other tissue being treated and the clinical objectives.
• the dressing can be changed periodically, such as, for example, one, two, or three times per week (or as needed).
• reduced pressure and “negative pressure” refer to a pressure that is below normal atmospheric pressure.
• Negative pressure wound and tissue treatments and other advanced technical interventions are becoming more prevalent given the occurrence of both the aging population, as well as the increasingly compromised patient populations. This trend looks set to continue. In wound care, healthcare professionals are now more likely to encounter wounds that are difficult to manage with a multitude of complex healing problems.
• a unitary negative pressure wound dressing construct that includes: (i) an absorbent layer having a first surface for contacting a wound and a second surface opposite the first surface, the absorbent layer comprising a gelling absorbent material and having a perimeter border, (ii) a cover layer having a first surface facing the absorbent layer and a second surface opposite the first surface, wherein the cover layer has a perimeter border having dimensions greater than the dimensions of the absorbent layer perimeter such that the perimeter border of the cover layer extends beyond the perimeter border of the absorbent layer, and (iii) a peripheral adhesive skin contact layer attached to the first surface of the absorbent layer adjacent the perimeter border of the absorbent layer, wherein the peripheral adhesive skin contact layer defines a window through which the absorbent layer is able to contact the wound, and wherein the peripheral adhesive skin contact layer comprises a hydrocolloid adhesive.
• the dimensions of the perimeter border of the absorbent layer are greater than dimensions of a wound to be covered by the dressing.
• the cover layer is water impermeable.
• the cover layer is water impermeable and air and vapour permeable.
• the peripheral adhesive skin contact layer has a perimeter border having dimensions greater than the dimensions of the absorbent layer perimeter such that the perimeter border of the peripheral adhesive skin contact layer extends beyond the perimeter border of the absorbent layer.
• the perimeter border of the cover layer and the perimeter border of the peripheral skin contact layer are bonded together to form a seal.
• the peripheral adhesive skin contact layer is operable to adhere to skin surrounding a wound.
• the cover layer defines an aperture configured for connection to a source of negative pressure.
• the peripheral adhesive skin contact layer and the cover layer are operable to form an air-tight seal between the absorbent layer and an external environment of the dressing when the dressing is applied over a wound and a source of negative pressure is sealingly connected to the aperture.
• the peripheral adhesive skin contact layer has a thickness of from about 0.1 mm to about 5 mm.
• the peripheral adhesive skin contact layer has a width of from about 2 cm to about 6 cm.
• the dressing further includes a first bonding layer positioned between the absorbent layer and the cover layer.
• the first bonding layer comprises a layer of hydrocolloid adhesive.
• the first bonding layer has a thickness of from about 0.2 mm to about 2 mm.
• the dressing further includes a structural layer corresponding to the peripheral adhesive skin contact layer and having a first surface bonded to the peripheral adhesive skin contact layer, and a second bonding layer corresponding to the peripheral adhesive skin contact layer and positioned in contact with a second surface of the structural layer that is opposite the first surface of the structural layer.
• the structural layer is positioned between, and sealingly bonded to, the peripheral adhesive skin contact layer and the second bonding layer.
• the second bonding layer is sealingly bonded to a continuous portion of the first surface of the absorbent layer that is adjacent the full perimeter border of the absorbent layer.
• the peripheral adhesive skin contact layer, the second bonding layer and the cover layer are operable to form an air-tight seal between the absorbent layer and an external environment of the dressing when the dressing is applied over a wound and a source of negative pressure is sealingly connected to the aperture.
• the structural layer comprises a polyurethane film.
• the second bonding layer has a thickness of from about 0.2 mm to about 2 mm.
• the dressing further includes a first bonding layer positioned between the absorbent layer and the cover layer, a structural layer corresponding to the peripheral adhesive skin contact layer and having a first surface bonded to the adhesive skin contact layer, and a second bonding layer corresponding to the peripheral adhesive skin contact layer and positioned in contact with a second surface of the structural layer that is opposite the first surface of the structural layer.
• the structural layer is positioned between, and sealingly bonded to, the peripheral adhesive skin contact layer and the second bonding layer.
• the second bonding layer is sealingly bonded to a continuous portion of the first surface of the absorbent layer that is adjacent the full perimeter border of the absorbent layer.
• the gelling absorbent material comprises a gel-forming fiber or filament.
• the gel-forming fiber or filament comprising chemically-modified cellulose, alginate, carboxymethyl cellulose, or combinations thereof.
• the absorbent layer comprises stitches.
• the absorbent layer further comprises an antimicrobial agent.
• the cover layer comprises a member selected from the group consisting of a polyurethane (PU), a polyvinyl chloride (PVC), a silicone elastomer, a fluoropolymer, and combinations thereof.
• the dressing further includes a source of negative pressure sealingly connected to the aperture and in fluid communication with the absorbent layer.
• the source of negative pressure comprises a pump connected to the aperture.
• the pump is connected to the aperture with a conduit.
• the dressing further includes a connector attached to the cover layer over the aperture and configured for connection to a conduit to communicate negative pressure from the conduit to the wound through the aperture.
• the connecter comprises polyurethane or polyvinylchloride.
• the connecter comprises a change indicator.
• the dressing further includes a negative pressure distribution layer positioned between the absorbent layer and the cover layer.
• the negative pressure distribution layer comprises an open cell foam layer.
• the open cell foam layer is hydrophobic.
• a disposable negative pressure wound therapy device that includes a disposable pump for generating negative pressure, and a dressing according to any of the embodiments disclosed herein for covering and protecting a wound, wherein the cover layer defines an aperture connected to the pump.
• the disposable pump is a battery operated pump.
• the device further includes a conduit defining a lumen that provides fluid communication between the pump and the aperture defined in the cover layer of the dressing, whereby operation of the pump creates negative pressure at the site of a wound when the dressing is affixed over the wound by pressure sealing the peripheral adhesive skin contact layer to skin surrounding the wound.
• Fig. 1 illustrates a schematic top view one dressing embodiment according to the disclosure.
• Fig. 2 illustrates a cross-sectional side view of the dressing embodiment shown in Fig. 1.
• FIG. 3 illustrates another cross-sectional side view of the dressing embodiment shown in
• Fig. 4 illustrates a schematic top view another dressing embodiment according to the disclosure.
• Fig. 5 illustrates a cross-sectional side view of the dressing embodiment shown in Fig. 4.
• Fig. 6 illustrates another cross-sectional side view of the dressing embodiment shown in
• Fig. 7 illustrates a cross-sectional side view of another dressing embodiment according to the disclosure.
• FIG. 8 illustrates another cross-sectional side view of the dressing embodiment shown in
• One aspect of the disclosure is a dressing that includes an absorbent layer comprising a gelling absorbent material, a cover layer composed of a water impermeable and air and vapour permeable material overlying the absorbent layer, and a peripheral adhesive skin contact layer situated beneath the peripheral border of the absorbent layer to sealingly affix the dressing to a patient’s skin.
• the term “beneath” means “on the opposite side from the skin cover layer.”
• the peripheral adhesive skin contact layer comprises a hydrocolloid adhesive.
• the cover layer defines an aperture configured for connection to a source of negative pressure.
• Vacuum wound therapy can be used for the treatment of a multitude of wound types, including but not limited to, acute wounds (such as, following fasciotomy or other surgeries), chronic wounds (such as pressure ulcers, trophic and vascular ulcers), and the management of complex soft tissue injuries (such as, open abdomen (laparotomy)).
• acute wounds such as, following fasciotomy or other surgeries
• chronic wounds such as pressure ulcers, trophic and vascular ulcers
• complex soft tissue injuries such as, open abdomen (laparotomy)
• first, second, third, etc. may be used herein to describe various elements, components, regions, layers and/or sections, these elements, components, regions, layers and/or sections should not be limited by these terms. These terms may be only used to distinguish one element, component, region, layer or section from another region, layer or section. Terms such as “first,” “second,” and other numerical terms when used herein do not imply a sequence or order unless clearly indicated by the context. Thus, a first element, component, region, layer or section discussed herein could be termed a second element, component, region, layer or section without departing from the teachings of the example embodiments.
• ranges and amounts can be expressed as “about” a particular value or range. About also includes the exact amount. For example, “about 5 m L” means “about 5 pL” and also “5 pL.” Generally, the term “about” includes an amount that would be expected to be within experimental error. The term “about” includes values that are within 10% less to 10% greater of the value provided. For example, “about 50%” means “between 45% and 55%.” Also, by way of example, “about 30” means “between 27 and 33.”
• the terms “individual(s)”, “subject(s)” and “patient(s)” mean any mammal. In some embodiments, the mammal is a human. In some embodiments, the mammal is a non-human.
• exudate refers to any fluids produced by a wound that may be secreted from the wound.
• peripheral refers to the area directly bordering the wound area itself.
• peripheral skin refers to the skin area directly bordering the wound area itself.
• negative pressure and reduced pressure generally refer to a pressure less than the ambient pressure at a tissue site that is being subjected to treatment. In most cases, this reduced pressure will be less than the atmospheric pressure at which the patient is located. Alternatively, the reduced pressure may be less than a hydrostatic pressure associated with tissue at the tissue site. Although the terms “vacuum” and “negative pressure” may be used to describe the pressure applied to the tissue site, the actual pressure reduction applied to the tissue site may be significantly less than the pressure reduction normally associated with a complete vacuum. [0042] As used herein, the term “moldable” refers to an elastic, deformable property and ability to conform and/or form a seal.
• the moldable materials of various embodiments disclosed herein may be differentiated from stretchable and flexible materials.
• the term, “moldable” can encompass the properties of malleability and ductility.
• the absolute shape change of a moldable material may be controlled by an external resistive element resulting in conformance to a complimentary feature.
• the term “flexible” refers to the elastic deformation of a structure under an external force. Upon removal of the external force the structure will substantially return to its original (previous) geometry. Measurement of flexibility can be quantified in linear displacement (mpi, mm, cm, m), e.g., original length/diameter and flexed length/diameter. The second moment of area influences the deformation experienced by the body.
• a device which is moldable can also have the property of flexibility. Flexibility is desirable in dressings. Skin flexes during the movement and activities of daily living, especially in areas over joint tissues. Rigid systems would not be able continually adapt to the skin flexibility. However, flexible devices are capable of continually adapting to the skin and mucosal membranes flexibility.
• adheresive refers to layers, fabrics, strips, laminates, barriers and materials that are used to promote adherence of a dressing to the skin and/or promote a seal between layers of the dressing to one another, thereby preventing undesirable leakage of effluent and providing an effective environment for application of negative pressure.
• dressing 100 includes absorbent layer 110, cover layer 120 and peripheral adhesive skin contact layer 130. While the dressings disclosed herein can have a wide variety of shapes and sizes, for the sake of convenient description, dressing 100 depicted in Figs. 1-3 has a generally rectangular shape with a length dimension L and a width dimension W.
• Absorbent layer 110 has first surface 112 for contacting a wound and second surface 114 opposite first surface 112, and has perimeter border 116 preferably having dimensions greater than the dimensions of a wound to be covered by dressing 100.
• Cover layer 120 has first surface 122 facing absorbent layer 110 and has second surface 124 opposite first surface 122, and has perimeter border 126 that extends beyond perimeter border 116 of absorbent layer 110. As such, perimeter border 126 has dimensions greater than dimensions of perimeter border 116 of absorbent layer 110.
• Peripheral adhesive skin contact layer 130 is attached to first surface 112 of absorbent layer 110 adjacent its perimeter border 116. Peripheral adhesive skin contact layer 130 has an inner edge 132 that defines a window 134 through which first surface 112 of absorbent layer 110 is able to contact a wound over which dressing 100 is applied.
• first surface 122 of cover layer 120 is bonded to first surface 114 of absorbent layer by an adhesive. In other embodiments, at least a portion of cover layer 120 adjacent its perimeter 126 is bonded to a portion of absorbent layer 110 adjacent its perimeter 116. In some embodiments, first surface 122 of cover layer 120 is bonded to first surface 114 of absorbent layer by positioning a bonding layer between absorbent layer 110 and cover layer 120. In some embodiments the bonding layer comprises an adhesive. In some embodiments, the bonding layer comprises a layer of hydrocolloid adhesive.
• Dressing 100 is configured to be held in place over a wound by peripheral skin contact layer 130, which extends around the border of the dressing and defines a window therethrough.
• Peripheral adhesive skin contact layer 130 is composed of a material that is capable of durably and strongly adhering to skin to form a seal.
• the durability of the dressing’s adherence to a patient’s skin is an important factor in the prevention of an unacceptable level of leakage during application of negative pressure wound therapy.
• a person of ordinary skill understands that such durability is directly proportional to the properties of the composition used to make the peripheral skin contact layer 130, which impacts the strength of adherence between the peripheral adhesive skin contact layer and underlying skin, and also is directly proportional to the width W 1 of peripheral adhesive skin contact layer 130.
• peripheral adhesive skin contact layer 130 has a width of from about 1 cm to about 10 cm. In another embodiment, peripheral adhesive skin contact layer 130 has a width of from about 2 cm to about 6 cm. In still another embodiment, peripheral adhesive skin contact layer 130 has a width of from about 2 cm to about 5 cm
• Peripheral adhesive skin contact layer 130 and cover layer 120 are operable to form an air-tight seal between the absorbent layer and an external environment of dressing 100 when dressing 100 is applied over a wound and a source of negative pressure is sealingly connected to aperture 128.
• a removable film referred to herein as a “removable backing” (not shown) may be adhered to an outer surface (also referred to as “bottom surface”) of peripheral adhesive skin contact layer 130, which removable backing is to be removed before use of dressing 100.
• the removable backing may be adhered to the outer surface of peripheral adhesive skin contact layer 130 opposite the side of peripheral adhesive skin contact layer 130 that faces toward cover layer 126.
• the removable backing which may include multiple sections and may include folded grip sections, is removable from peripheral adhesive skin contact layer 130 before use of dressing 100.
• the removable backing protects peripheral adhesive skin contact layer 130 when the removable backing is adhered to peripheral adhesive skin contact layer 130, but when the removable backing is removed from peripheral adhesive skin contact layer 130 for use of dressing 100 the outer surface of peripheral adhesive skin contact layer 130 is exposed and able to releasably secure dressing 100 to the skin of a user to provide a deformable pressure seal around the wound.
• the removable backing in some embodiments is also sized to cover the entire bottom surface of dressing 100, including the bottom surface of peripheral adhesive skin contact layer 130 and also any exposed portion of any other layer, such as, for example, the portion of absorbent layer 110 that is exposed through window 134.
• Absorbent layer 110 is composed of a gelling absorbent material.
• the gelling absorbent material preferably is capable of absorbing exudate from a wound and allowing passage of fluid through it.
• Absorbent layer 110 may have an open weave structure with pockets available for fluid absorption.
• the absorbent layer may be nonwoven, knitted or formed of a tight weave.
• the absorbent layer is a nonwoven. The absorbent layer can expand upon absorption of exudate or other fluid produced from the wound site.
• the absorbent layer comprises a gel-forming fiber, filament, or agent.
• the gel-forming fiber or filament is chemically-modified cellulose, alginate, or carboxymethyl cellulose, or a combination thereof.
• the gel forming fiber is carboxymethyl cellulose.
• the absorbent layer also can include other absorbent materials such as, for example, polyacrylate, polyacrylate fibers, bi-component superabsorbent fibers, air laid nonwovens, needlefelt nonwovens, thermobonded nonwovens and foams.
• Some formulations of the absorbent layer contain an alginate to increase absorption capabilities.
• the active surface of the absorbent layer can be coated with a cross-linked adhesive mass containing a dispersion of gelatin, pectin and/or carboxymethyl cellulose together with other polymers.
• the polysaccharides and other polymers absorb water and swell, forming a gel.
• the moist conditions produced under the dressing are intended to promote fibrinolysis, angiogenesis and wound healing, without causing softening and breaking down of tissue.
• Absorbent layer 110 preferably comprises gel forming fibres.
• gel forming is meant hygroscopic fibres which upon the uptake of wound exudate become moist slippery or gelatinous and thus reduce the tendancy for the surrounding fibres to adhere to the wound.
• the gel forming fibres can be of the type which retain their structural integrity on absorption of exudate or can be of the type which lose their fibrous form and become a structureless gel.
• the gel forming fibres are preferably spun sodium carboxymethylcellulose fibres, chemically modified cellulosic fibres, pectin fibres, alginate fibres, chitosan fibres, hyaluronic acid fibres, or other polysaccharide fibres or fibres derived from gums.
• the gel forming fibres are preferably sodium carboxymethylcellulose fibres, chemically modified cellulosic fibres, alkyl sulphonate modified cellulosic fibres such as those described in WO2012/061225, pectin fibres, alginate fibres, chitosan fibres, hyaluronic acid fibres, or other polysaccharide fibres or fibres derived from gums.
• the gel forming fibres are preferably chemically modified cellulosic fibres in the form of a fabric and in particular carboxymethylated cellulose fibres as described in PCT WO00/01425 to Azko Nobel UK Ltd.
• the cellulosic fibres preferably have a degree of substitution of at least 0.05 carboxymethyl groups per glucose unit.
• the cellulosic fibres have a degree of substitution of from about 0.12 to about 0.35 as measured by IR spectroscopy (as defined in WO 00/01425). In another embodiment, the cellulosic fibres have a degree of substitution of from about 0.20 to about 0.30 and are made by carboxymethylating a woven, knitted, or non-woven cellulosic fabric such that the absorbency is increased.
• the gel forming fibres preferably have an absorbency of at least 2 grams 0.9% saline solution per gram of fibre (as measured by the free swell method).
• the gel forming fibres have an absorbency of at least 10 g/g as measured in the free swell absorbency method, more preferably, between 15 g/g and 25 g/g.
• the gelling absorbent material can be made in accordance with the disclosure of WO 93/12275, which describes the production of various absorbent carboxymethylated cellulosic products that are capable of absorbing many times their own weight of water. This causes the carboxymethylated fibres to form a gel.
• WO 94/16746 and WO 00/01425 describe the use of carboxymethylated Lyocell materials in wound dressings where the advantages of gel formation in preventing adherence and therefore reducing wound damage and pain on removal are described.
• Carboxymethylation can be achieved, for example, by sequential or simultaneous treatment of the cellulosic material with a strong alkali, such as aqueous sodium hydroxide, and monochloroacetic acid or a salt thereof.
• the appropriate reaction conditions will depend upon the composition of the fabric and the degree of carboxymethylation required and will be readily apparent to the person skilled in the art. They may be identical or similar to those described in WO 93/12275, WO 94/16746 or WO 00/01425. Desirably the carboxymethylation is carried out in the presence of industrial methylated spirits (IMS), and IMS is preferably also used in a subsequent washing step, suitably along with water, as a cleaner and steriliser.
• the degree of carboxymethylation is desirably such that upon absorption of exudate the fibres at the skin contacting surface of the bandage form a gel.
• absorbent layer 110 comprises carboxymethylated cellulose fibres formed into a fabric. In other embodiments, absorbent layer 110 comprises two or more layers of fabric comprising carboxymethylated cellulose fibres. In one embodiment, absorbent layer 110 comprises from about two to about ten layers of fabric comprising carboxymethylated cellulose fibres. In another embodiment, absorbent layer 110 comprises from about two to about eight layers of fabric comprising carboxymethylated cellulose fibres.
• absorbent layer 110 comprises one or more layers of fabric comprising carboxymethylated cellulose fibres
• absorbent layer 110 further comprises stitching to increase the tensile strength and/or the resilience of dressing 100.
• the stitching can be present in only one or in more than one fabric layer.
• stitching is present in the fabric layer that is positioned to contact the wound in use of dressing 100.
• Stitching contemplated by this disclosure can include inelastic threads or yarns and/or resilient thread or yarn.
• WO 2007/003905 describes dressings in which stitching is used to increase the tensile strength of dressings, which are particularly suitable for use in dressing burns.
• US 10,117,783 describes dressings in which stitching is used to increase the resilience of dressings, which are particularly suitable for use in dressings placed on body positions were movement occurs, such as joints (e.g., elbows, knees, hips, etc.) or abdomen.
• resilient is meant that the yarn or thread is able to extend and contract to its former shape.
• the gathers in the absorbent layer formed by the resilient thread or yarn enable the absorbent layer to extend and contract with movement so that when, for example, the patient's leg is bent the dressing stretches and when the leg is straightened, the dressing recovers its former size.
• This resilience means that the absorbent layer maintains close conformability with the wound during movement of the patient.
• the dressing has a reduced tendency to delaminate during wear. Having the ability to stretch means that there is less movement between the dressing and the patient which enables a more durable seal between the dressing and the patient’s underlying skin.
• the absorbent layer further comprises lines of longitudinal warp stitches formed from an inelastic thread which stitching is longitudinal in that it is generally parallel to the long dimension of the absorbent layer.
• the warp stitches are preferably made in the absorbent layer after it has been formed.
• the inelastic warp stitching preferably passes through the whole thickness of the absorbent layer and is visible on both sides.
• the absorbent layer preferably comprises two or more layers of fabric that are layered together and stitch bonded with lines of longitudinal inelastic warp stitches.
• the resilient thread is preferably woven in between the stitches of the inelastic warp stitching and in between the sheets of fabric. By having two layers of fabric it is possible to hold the resilient thread or yarn out of direct contact with the wound.
• the resilient thread gathers the absorbent layer and enables it to elongate and then return to shape.
• the resilient thread can be stitched through the absorbent layer to gather the dressing or woven through a separate line of inelastic warp stitches.
• the resilient thread can be stitched through the absorbent layer in lines of longitudinal stitches 1 mm to 10 mm apart, more preferably 2 mm to 5 mm apart.
• the resilient thread is preferably applied to the absorbent layer after the absorbent layer has been formed.
• the lines of inelastic warp stitching may be from 1 mm to 10 mm apart and preferably from 2 mm to 5 mm apart.
• the lines of inelastic stitching are typically crocheted or knitted and have the appearance of a chain stitch but other stitch patterns may also be used.
• the lines of resilient stitching gather the absorbent layer so that the absorbent layer is able to elongate by 25% to 85%, more preferably 35% to 75% and most preferably 40% to 70% and then recover even when the absorbent layer is hydrated.
• the lines of warp stitching are made in a yarn or thread such as nylon or polyester or Tencel® (Lenzing Aktiengesellschaft) or any thread which is strong and easily processed.
• the resilient stitches are made in a resilient yarn such as an elastomeric yarn or Lycra or other yarn which has good stretch and recovery or an elastane yarn which is an elastomeric yarn with greater than 85% polyurethane such as Lycra® (The Lycra Company) or Spandex.
• a resilient yarn such as an elastomeric yarn or Lycra or other yarn which has good stretch and recovery or an elastane yarn which is an elastomeric yarn with greater than 85% polyurethane such as Lycra® (The Lycra Company) or Spandex.
• absorbent layer 110 it is made from a non-woven roll made by forming a web of Lyocell which is then hydroentangled. The web is then carboxymethylated by sequential or simultaneous treatment of the cellulosic material with a strong alkali, monochloroacetic acid or a salt thereof. Two webs of the resulting fabric are then fed into a stitch bonding machine and stitched simultaneously with lines of longitudinal stitching in an inelastic yarn and a resilient yarn woven in between the stitches and so secured at the centre of the webs. The resilient yarn gathers the absorbent layer (not shown) and is carried by the inelastic stitch bonded yarn. The resulting layer has a basis weight of 350 gm 2 .
• absorbent layer 110 it is made from a tow of carboxymethyl cellulose filaments which has been needlefelted. Two webs of the needlefelted tow are fed into a stitch bonding machine and stitched simultaneously with lines of longitudinal stitching in inelastic yarn and with a resilient yarn woven in between the stitches and so secured at the centre of the webs.
• absorbent layer 110 is provided with fenestrations to aid the application of negative pressure to the wound and maintain the pathway for fluid from the wound, through the absorbent layer.
• fenestrations are only provided in internal absorbent layers.
• Absorbent layer 110 may comprise one or more medicaments.
• an antimicrobial agent or an antibiotic, or an anaesthetic on an anti-inflammatory agent or a skin protective agent or an odour absorbing agent.
• the absorbent layer comprises an antimicrobial agent that can inhibit the growth of gram negative bacteria and/or gram positive bacteria.
• the antimicrobial agent can kill microbes, inhibit microbes’ growth cycle, or disrupt the formation of microbial biofilms. Antimicrobial agents inhibit the growth of bacteria and thus, promote healthy wound healing.
• Cover layer 120 may be any material that provides a fluid seal.
• a fluid seal is a seal adequate to maintain reduced pressure at a desired site given the particular reduced pressure source or subsystem involved.
• the cover layer may be, for example, an impermeable or semi-permeable, elastomeric material. For semi-permeable materials, the permeability must be low enough that for a given reduced-pressure source, the desired reduced pressure may be maintained.
• the cover layer may be waterproof.
• the cover layer comprises polyester, polyurethane (PU), polyvinyl chloride (PVC), silicone elastomer, or fluoropolymers.
• the cover layer may comprise polyester or polyurethane film.
• Cover layer 120 is adapted to enable negative pressure to be applied at the wound and defines an aperture therethrough configured for connection to a source of negative pressure.
• the aperture comprises a port configured for attachment to a conduit that is, in turn, configured for attachment to a source of negative pressure.
• the dressing provides a fluid pathway from the wound, through the absorbent layer and the aperture to the conduit.
• the port is preferably located in that part of the cover layer that overlies the absorbent layer but towards the periphery of the absorbent layer so that it is not directly in vertical alignment with the centre of the dressing (or the wound when in use). This assists in the spread of exudate across the full extent of the absorbent layer.
• cover layer 120 of dressing 100 is a bacterial and viral barrier layer which preferably resists the ingress of liquid and air but allows moisture vapour transmission.
• the outer cover layer enhances the overall fluid handling capacity of the dressing by allowing for the escape of moisture vapour through the cover while enabling the application of negative pressure to the wound.
• the outer cover layer is for instance a layer having a MVTR of at least 10,000 gm 2 per 24 hours or in the range of from 10,000 gm 2 to 50,000 gm 2 per 24 hours measured by the method described in BS EN 13726-22002 “Test methods for primary wound dressings Part 2 Moisture vapour transmission rate of permeable film dressings.”.
• the cover layer may be in the form of a film of polyurethane, for example Epurex 92 T/129 manufactured by Covestro or Inspire 2350 manufactures by Coveris or Medifilm 426 manufactured by Mylan.
• Peripheral Adhesive Skin Contact layer 130 may be of the type comprising a homogenous blend of one or more water soluble hydrocolloids and one or more low molecular weight polyisobutylenes such as are described in EP-B-92999 incorporated herein by reference.
• the water soluble hydrocolloids may be selected from sodium carboxymethylcellulose, pectin, gelatine, guar gum, locust bean gum, karaya gum, and mixtures thereof.
• the polyisobutylenes may be selected from low molecular weight polyisobutylenes having a viscosity average molecular weight of from 36,000 to 58,000 (Florey).
• the peripheral adhesive skin contact layer is capable of absorbing exudate while maintaining adhesion of the dressing to the skin.
• the adhesive composition may comprise a homogeneous blend of one or more hydrocolloids, one or more low molecular weight polyisobutylenes, one or more styrene block copolymers, mineral oil, butyl rubber, a tackifier and small amounts of optional components.
• an adhesive composition may be prepared having good adhesion to the skin and stretchability. Such compositions and the preparation therefore are disclosed in EP-B- 130061.
• the composition of peripheral adhesive skin contact layer 130 is such that the removal of an adhesive wound dressing is not traumatic to the patient.
• the peripheral adhesive skin contact layer ensures a secure application of the dressing whist still permitting non- traumatic removal.
• Non-traumatic dressing removal may be facilitated by using an adhesive which gels slightly upon interaction with a fluid. The gel formation aids dressing removal.
• hydrocolloid adhesive refers to an adhesive material or substance that comprises a hydrocolloid.
• the formulation of these adhesives may be modulated to adjust physical properties of the material (e.g., its ability to create a vacuum seal, flexibility, breathability, comfort, size, etc.).
• the peripheral adhesive skin contact layer is at least 1%, at least 5%, at least 10%, at least 15%, at least 20%, at least 30%, at least 40%, or at least 50 % w/w hydrocolloid.
• Peripheral adhesive skin contact layer 130 is operable to provide a seal between the peripheral adhesive skin contact layer and the skin, thereby preventing exudate leakage.
• the peripheral adhesive skin contact layer has a thickness of from about 0.1 mm to about 5 mm. In other embodiments, the skin contact layer has a thickness of from about 0.15 mm to about 3 mm. In yet other embodiments, the skin contact layer has a thickness of from about 0.2 mm to about 2 mm.
• dressing 200 includes many features corresponding to those of dressing 100, and also includes first bonding layer 240, reinforcing structural support layer 250 (also referred to as structural layer 250) and second bonding layer 260.
• First bonding layer 240 lies between cover layer 220 and absorbent layer 210 and operates to adhere cover layer 220 to absorbent layer 210.
• Structural layer 250 overlays peripheral adhesive skin contact layer 230 and functions as a scrim to add stability to peripheral adhesive skin contact layer 230.
• Structural layer 240 helps to reduce any tendency of peripheral adhesive skin contact layer 230 to delaminate on dressing removal.
• Second bonding layer 260 overlies structural layer 250 to bond structural layer 250 and the underlying peripheral adhesive skin contact layer 230 to absorbent layer 210. As shown most clearly in Fig. 6, second bonding layer 260 and structural layer 250 also define a window cut therefrom that coincide with window 234 in peripheral adhesive skin contact layer 230 to enable direct contact between absorbent layer 210 and an underlying wound.
• Absorbent layer 210 has first surface 212 for contacting a wound and second surface 214 opposite first surface 212, and has perimeter border 216 having dimensions greater than the dimensions of a wound to be covered by dressing 200.
• Cover layer 220 has first surface 222 facing absorbent layer 210 and has second surface 224 opposite first surface 222, and has perimeter border 226 that extends beyond perimeter border 216 of absorbent layer 210. As such, perimeter border 226 has dimensions greater than dimensions of perimeter border 216 of absorbent layer 210.
• first bonding layer 240 Between first surface 222 of cover layer 220 and second surface 214 of absorbent layer 210 is positioned between first surface 222 of cover layer 220 and second surface 214 of absorbent layer 210 is positioned first bonding layer 240.
• peripheral adhesive skin contact layer 230 and first surface 212 of absorbent layer 210 adjacent its perimeter border 216 are situated structural layer 250 and second bonding layer 260, oriented such that structural layer 250 is adjacent to, and bonded to, peripheral adhesive skin contact layer 230, and second bonding layer 260 is situated between structural layer 250 and first surface 212 of absorbent layer 210, thereby bonding structural layer 250 to absorbent layer 210 in the area of peripheral border 216 of absorbent layer 210.
• Peripheral adhesive skin contact layer 230 has an inner edge 232 that coincides with inner edges of structural layer 250 and second bonding layer 260, together defining a window 234 through which first surface 212 of absorbent layer 210 is able to contact a wound over which dressing 200 is applied.
• peripheral adhesive skin contact layer 230 is bonded to structural layer 250, which is bonded to second adhesive layer 260, which is bonded to first adhesive layer 240, which is bonded to cover layer 220.
• peripheral skin contact layer 230 when peripheral skin contact layer 230 is affixed to a patient’s skin surrounding a wound, peripheral skin contact layer 230, structural layer 250, second bonding layer 260 and first bonding layer 240, together with cover layer 220 and the patient’s skin, form an airtight seal around the perimeter of dressing 200, providing therein a sealed chamber in which the patient’s wound is in fluid communication with absorbent layer 210 and with aperture 228 in cover layer 220.
• structural layer 250 comprises a polymer selected from, but not limited to, polypropyleneoxide, polyurethane, polyacrylate, ethylene vinyl acetate, and combinations thereof.
• the polymer is formed into a thin film.
• the structural layer comprises a polyurethane film.
• first bonding layer 240 comprises an adhesive.
• bonding layer 240 comprises a hydrocolloid adhesive, for example Pectin, Gelatin, NaCMC - Sodium Carboxymethyl Cellulose.
• the adhesive may be at least 1%, at least 5%, at least 10%, at least 15%, at least 20%, at least 30%, at least 40%, or at least 50 % w/w hydrocolloid.
• First bonding layer 240 can be composed of the same hydrocolloid adhesive as peripheral adhesive skin contact layer 230 or can be composed of a different adhesive than peripheral adhesive skin contact layer 230.
• first bonding layer 240 has a thickness of from about 0.1 mm to about 5 mm. In some embodiments, first bonding layer 240 has a thickness of from about 0.2 mm to about 3 mm. In some embodiments, first bonding layer 240 has a thickness of from about 0.2 mm to about 2 mm. In some embodiments, first bonding layer 240 has a thickness of from 0.2 mm to about 1 mm. Second Bonding Layer
• second bonding layer 260 comprises an adhesive.
• second bonding layer 260 comprises a hydrocolloid adhesive, for example Pectin, Gelatin, NaCMC - Sodium Carboxymethyl Cellulose.
• the adhesive may be at least 1%, at least 5%, at least 10%, at least 15%, at least 20%, at least 30%, at least 40%, or at least 50 % w/w hydrocolloid.
• Second bonding layer 260 can be composed of the same hydrocolloid adhesive as peripheral adhesive skin contact layer 230 or can be composed of a different adhesive than peripheral adhesive skin contact layer 230.
• second bonding layer 260 has a thickness of from about 0.1 mm to about 5 mm. In some embodiments, second bonding layer 260 has a thickness of from about 0.2 mm to about 3 mm. In some embodiments, second bonding layer 260 has a thickness of from about 0.2 mm to about 2 mm. In some embodiments, second bonding layer 260 has a thickness of from 0.2 mm to about 1 mm.
• a negative pressure distribution layer is included in the dressing.
• dressing 300 includes many features corresponding to those of dressings 100 and 200, and also includes negative pressure distribution layer 370 positioned between absorbent layer 310 and cover layer 320.
• first bonding layer 340 is situated between negative pressure distribution layer 370 and cover layer 320.
• additional layers may be included in dressing 300 (and in other dressing embodiments described herein) between and/or among the layers shown without departing from the disclosure.
• negative pressure distribution layer 370 is positioned within absorbent layer 310 or, stated alternatively, dressing 300 includes two absorbent layers, one being positioned as shown in Figs.
• absorbent layer 310 absorbent layer 7 and 8 (absorbent layer 310) and another being positioned, fully or partly, between pressure distribution layer 370 and cover layer 320.
• Both absorbent layers in such an embodiment can be composed of materials as described herein in connection with absorbent layers 110, 210, 310, and can have the same composition as one another or different compositions from one another.
• one or more additional bonding layers may also be included, if desired, to achieve acceptable bonding of layers to one another within the dressing.
• negative pressure distribution layer 370 has length and width dimensions corresponding to the length and width dimensions of absorbent layer 310. In other embodiments, negative pressure distribution layer 370 has dimensions different than absorbent layer 310.
• negative pressure distribution layer 370 is also situated, along with absorbent layer 310, within an airtight sealed chamber of dressing 300 that is formed by peripheral skin contact layer 330, structural layer 350, second bonding layer 360 and first bonding layer 340, together with cover layer 320 and the patient’s skin.
• the patient’s wound is in fluid communication with absorbent layer 310, negative pressure distribution layer 370 and aperture 228 in cover layer 320.
• negative pressure distribution layer 370 is gas and liquid permeable and particularly moisture vapour permeable and serves to aid access of exudate to a greater area of absorbent layer 310 by distributing negative pressure laterally over dressing 300 and allowing exudate to spread under negative pressure distribution layer 370.
• Negative pressure distribution layer 370 also serves to even out the negative pressure applied to the wound over the whole dressing. Negative pressure distribution layer 370 preferably distributes exudate and negative pressure over the dressing. In this way, uptake of exudate by absorbent layer 310 is maximised and a more uniform transfer of negative pressure to the wound, or dressing 300, is optimized.
• negative pressure distribution layer 370 is a foam layer such as a polyester foam of the type XD4200AS manufactured by Caligen or another suitable reticulated foam.
• negative pressure distribution layer 370 can comprise or be formed from any suitable material, for example, a material which can allow the transport of negative pressures to a wound site and/or which can channel and/or wick wound fluid and/or wound debris away from the wound site.
• negative pressure distribution layer 370 can comprise or be formed from a material selected from the group consisting of a nonwoven material, a polymer and a combination thereof.
• negative pressure distribution layer 370 may be formed from a nonwoven material.
• the nonwoven material may comprise natural fibers, synthetic fibers, continuous fibers, staple fibers, discontinuous fibers, bicomponent fibers and combinations thereof.
• the nonwoven material may comprise polyolefin fibers (e.g., polypropylene, polyethylene), polyester, polyethylene terephthalate (PET), nylon, cotton, and combinations and copolymers thereof.
• a nonwoven material may be formed from various process known in the art, for example, meltblowing processes, spunbonding processes, spunlaid processes, airlaid processes, wetlaid processes, thermal bonded processes, bonded carded web processes, and combinations thereof. Examples of non-woven materials include, but are not limited to, co polyester from Libeltex BVBA and HRM or polyolefin fibers in a matrix from Essentra.
• negative pressure distribution layer 370 may be formed from a polymer, for example, a thermoplastic elastomer (TPE), silicone, or a foam.
• TPE thermoplastic elastomer
• TPU thermoplastic polyurethane
• Negative pressure distribution layer 370 may be formed by combining sheets of TPE or TPU having a thickness between about 0.2 mm and about 2.0 mm.
• the sheets of TPE or TPU may be bonded, welded, adhered, or otherwise coupled to one another.
• the sheets of TPE or TPU may be welded using radiant heat, radio-frequency welding, or laser welding. Supracor, Inc., Hexacor,
• negative pressure distribution layer 370 may be formed from a 3D textile, also referred to as a spacer fabric. Suitable 3D textiles may be produced by Heathcoat Fabrics, Ltd., Baltex, and Mueller Textil Group.
• negative pressure distribution layer 370 may be formed from foam.
• foam For example, cellular foam, open-cell foam, reticulated foam, or porous tissue collections, may be used to form negative pressure distribution layer 370.
• negative pressure distribution layer 370 may be formed of grey foam or Zotefoam.
• Grey foam may be polyester polyurethane foam having about 60 pores per inch (ppi).
• Zotefoam may be a closed-cell, cross-linked polyolefin foam.
• negative pressure distribution layer 370 may comprise or consist essentially of be reticulated polyurethane foam such as found in GRANUFOAMTM dressing or V.A.C. VERAFLOTM dressing, both available from Kinetic Concepts, Inc. of San Antonio, Texas.
• negative pressure distribution layer 370 may comprise or consist essentially of foam that is mechanically or chemically compressed to increase the density of the foam at ambient pressure.
• Foam that is mechanically or chemically compressed may be referred to as compressed foam or felted foam.
• Compressed foam may be characterized by a firmness factor, which may be defined as a ratio of the density of foam in a compressed state to the density of the same foam in an uncompressed state. For example, a firmness factor of 5 may refer to compressed foam having a density that is five times greater than a density of the same foam in an uncompressed state.
• Mechanically or chemically compressing foam may also reduce a thickness of the foam at ambient pressure when compared to the same foam that has not been compressed.
• Reducing a thickness of foam by mechanical or chemical compression may increase a density of the foam, which may increase the firmness factor of the foam.
• Increasing the firmness factor of foam may increase a stiffness of the foam in a direction that is parallel to a thickness of the foam.
• increasing a firmness factor of negative pressure distribution layer 370 may increase a stiffness of negative pressure distribution layer 370 in a direction that is parallel to the thickness of the layer.
• negative pressure distribution layer 370 may have a density of about 0.03 grams per centimeter 3 (g/cm 3 ) in its uncompressed state. In its compressed state, negative pressure distribution layer 370 may have a firmness factor (FF) of about 5, and the density may be about 0.15 g/cm 3 .
• the compressed foam exhibits less deformation or compression set than a similar uncompressed foam.
• the thickness of negative pressure distribution layer 370 may deform less than if negative pressure distribution layer 370 is formed of a comparable uncompressed foam. The decrease in deformation may be caused by the increased stiffness as reflected by the firmness factor. If subjected to the stress of negative pressure, negative pressure distribution layer 370 formed of compressed foam may flatten less than negative pressure distribution layer 370 that is formed from uncompressed foam.
• negative pressure distribution layer 370 when negative pressure is applied to negative pressure distribution layer 370, the stiffness of negative pressure distribution layer 370 in the direction parallel to the thickness of negative pressure distribution layer 370 can allow negative pressure distribution layer 370 to be more compliant or compressible in other directions, e.g., a direction parallel to the wound surface.
• the pore size of a foam material may vary according to needs of negative pressure distribution layer 370 and the amount of compression of the foam.
• uncompressed foam may have pore sizes in a range of about 400 microns to about 600 microns. If the same foam is compressed, the pore sizes may be smaller than when the foam is in its uncompressed state.
• negative pressure distribution layer 370 may be formed from a polymer via injection molding or extrusion techniques.
• negative pressure distribution layer 370 may be a single layer, for example as shown in Figs. 7 and 8.
• negative pressure distribution layer 370 may be multilayered.
• negative pressure distribution layer 370 may comprise two or more layers, three or more layers, four or more layers, etc.
• the dressing described in previous embodiments contains a connector to be used for fluid communication through the layers.
• a connector is coupled to the cover layer such that the connector allows fluid communication with the sealed space beneath the cover layer.
• the connecter is affixed to the aperture in the cover layer.
• the connector can be connected to a device used to produce a vacuum (such as a vacuum pump) in order to produce a reduced pressure under the cover layer.
• the connector can be constructed from semi-rigid material such as polyurethane film or polyvinyl chloride.
• semi-rigid materials include silicone, acrylics, cyanoacrylate, rubbers, foams, cellulose, polyurethanes, polyethylenes, polyvinyl chlorides, ethylenevinyl acetates, polypropylenes, polytetrafluorethylenes, and poly isobutylenes.
• the connector may contain additional textile material layers in order to slow down or modulate exudate draining.
• the connector may optionally contain a change disk indicator to alert the user when it is time to change the dressing.
• dressings disclosed herein can be configured for connection to a vacuum pump or other negative pressure source, for example, using flexible tubes.
• a fluid communication pathway is provided from the wound, through one or more layers of absorbent material disposed in the dressing, to the negative pressure source.
• the fluid communication pathway may extend though an aperture in the cover layer to the interior lumen of a tube, optionally via the interior lumen or conduit of a flexible connector.
• a typical flexible connector is elongate with an interior lumen or conduit that runs parallel to the longitudinal axis of the flexible connector, wherein the flexible connector is attachable to the opening in the cover layer of the dressing in an orientation such that the longitudinal axis of the flexible connector is substantially parallel to the plane of the cover layer.
• the flexible member may comprise a head portion for securement to the cover layer via adhesive or other means.
• the fluid communication pathway extends from the interior lumen or conduit of the flexible connector through the opening in the cover layer in a direction substantially perpendicular to the longitudinal axis of the flexible connector. Once secured, a fluid-tight seal may be formed between the flexible connector and the cover layer.
• the dressing embodiments described herein may be secured to the skin surrounding a wound and to a conduit that is configured for connection to a source of negative pressure by a connector located at the distal end of the conduit.
• Negative pressure is applied to the wound by the application of negative pressure through a pathway for fluid leading from the wound, through the absorbent layer, the aperture in the cover layer and to the distal end of the conduit.
• Optional fenestrations that may be present in the absorbent layer, assist with the absorbance of exudate and that application of negative pressure.
• the dressing according to any embodiment disclosed herein can include a mobile vacuum pump affixed the dressing in fluid communication with the aperture defined in the cover layer of the dressing.
• the dressing includes an “on board” vacuum system that includes a pump that is sufficiently small to be attached directly to the dressing. Such a configuration enables the manufacture and use of disposable dressing/pump combinations.
• a unitary negative pressure wound dressing construct that includes: (i) an absorbent layer having a first surface for contacting a wound and a second surface opposite the first surface, the absorbent layer comprising a gelling absorbent material, wherein the absorbent layer has a perimeter border, (ii) a cover layer having a first surface facing the absorbent layer and a second surface opposite the first surface, wherein the cover layer has a perimeter border having dimensions greater than dimensions of the absorbent layer perimeter such that the perimeter border of the cover layer extends beyond the perimeter border of the absorbent layer, and (iii) a peripheral adhesive skin contact layer attached to the first surface of the absorbent layer adjacent the perimeter border of the absorbent layer, wherein the peripheral adhesive skin contact layer defines a window through which the absorbent layer is able to contact the wound, and wherein the peripheral adhesive skin contact layer comprises a hydrocolloid adhesive, wherein the peripheral adhesive skin contact layer has a perimeter border having dimensions greater than the dimensions of the absorbent layer perimeter such that the perimeter border of the peripheral adhesive skin contact layer extends beyond
• the peripheral adhesive skin contact layer has a thickness of from about 0.1 mm to about 5 mm.
• peripheral adhesive skin contact layer has a width of from about 2 cm to about 6 cm.
• a dressing in accordance with any other embodiment disclosed herein further comprising a first bonding layer positioned between the absorbent layer and the cover layer, a structural layer corresponding to the peripheral adhesive skin contact layer and having a first surface bonded to the adhesive skin contact layer, and a second bonding layer corresponding to the peripheral adhesive skin contact layer and positioned in contact with a second surface of the structural layer that is opposite the first surface of the structural layer, wherein the structural layer is positioned between, and sealingly bonded to, the peripheral adhesive skin contact layer and the second bonding layer, and wherein the second bonding layer is sealingly bonded to a continuous portion of the first surface of the absorbent layer that is adjacent the full perimeter border of the absorbent layer.
• the gel forming fiber or filament comprising chemically-modified cellulose, alginate, carboxymethyl cellulose, or combinations thereof.
• absorbent layer further comprises an antimicrobial agent.
• cover layer comprises a member selected from the group consisting of a polyurethane (PU), a polyvinyl chloride (PVC), a silicone elastomer, a fluoropolymer, and combinations thereof.
• PU polyurethane
• PVC polyvinyl chloride
• silicone elastomer a silicone elastomer
• fluoropolymer a fluoropolymer
• a dressing in accordance with any other embodiment disclosed herein, wherein the source of negative pressure comprises a pump connected to the aperture with a conduit.
• the connecter comprises polyurethane or polyvinylchloride.
• a disposable negative pressure wound therapy device that includes: (i) a disposable pump for generating negative pressure, and (ii) a dressing in accordance with any dressing embodiment disclosed herein for covering and protecting a wound, wherein the cover layer defines an aperture connected to the pump.
• a device in accordance with any other embodiment disclosed herein further comprising: (iii) a conduit defining a lumen that provides fluid communication between the pump and the aperture defined in the cover layer of the dressing, whereby operation of the pump creates negative pressure at the site of a wound when the dressing is affixed over the wound by pressure sealing the peripheral adhesive skin contact layer to skin surrounding the wound.

Landscapes

• Health & Medical Sciences (AREA)
• Heart & Thoracic Surgery (AREA)
• Public Health (AREA)
• Vascular Medicine (AREA)
• Engineering & Computer Science (AREA)
• Biomedical Technology (AREA)
• Veterinary Medicine (AREA)
• Life Sciences & Earth Sciences (AREA)
• Animal Behavior & Ethology (AREA)
• General Health & Medical Sciences (AREA)
• Dermatology (AREA)
• Hematology (AREA)
• Anesthesiology (AREA)
• Chemical & Material Sciences (AREA)
• Dispersion Chemistry (AREA)
• Materials For Medical Uses (AREA)
• Media Introduction/Drainage Providing Device (AREA)
• Medicinal Preparation (AREA)

Priority Applications (7)

Applications Claiming Priority (2)

Publications (1)

Family

ID=74130271

Family Applications (1)

Country Status (9)

Cited By (1)

Families Citing this family (7)

Citations (11)

Family Cites Families (645)